Skip to main content
. Author manuscript; available in PMC: 2021 Dec 21.
Published in final edited form as: J Am Coll Cardiol. 2020 Aug 25;76(8):945–957. doi: 10.1016/j.jacc.2020.06.063

Figure 1.

Figure 1.

Use of Cardiovascular Medications in the Study Population.

Treatment rates for aspirin, statin, beta-blocker, angiotensin-converting enzyme inhibitor (ACEi) and/or angiotensin receptor blocker (ARB) and diuretics according to the presence or absence of myocardial infarction (MI)—unrecognized myocardial infarction (UMI) or recognized myocardial infarction (RMI). N = 2,349.